CAS 842133-18-0
:Canagliflozina
Descripción:
Canagliflozina es un medicamento utilizado principalmente en el manejo de la diabetes mellitus tipo 2. Pertenece a una clase de fármacos conocidos como inhibidores del cotransportador de sodio-glucosa 2 (SGLT2), que funcionan al prevenir la reabsorción de glucosa en los riñones, promoviendo así su excreción en la orina y reduciendo los niveles de glucosa en sangre. La fórmula química de Canagliflozina es C21H25ClO5S, y presenta un grupo sulfonilo, un moiety de clorobenceno y una estructura similar a la glucosa, que contribuyen a su actividad farmacológica. Canagliflozina se administra típicamente por vía oral y es conocido por sus beneficios potenciales más allá del control glucémico, incluyendo la pérdida de peso y la protección cardiovascular. Los efectos secundarios comunes pueden incluir infecciones del tracto urinario y deshidratación. Al igual que con cualquier medicamento, es esencial que los pacientes consulten a profesionales de la salud para obtener asesoramiento personalizado y monitoreo mientras utilizan Canagliflozina.
Fórmula:C24H25FO5S
InChI:InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1
Clave InChI:InChIKey=XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
SMILES:O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC=3SC(=CC3)C4=CC=C(F)C=C4)=C(C)C=C2
Sinónimos:- (1S)-1,5-Anhydro-1-C-(3-((5-(4-Fluorophenyl)-2-Thienyl)Methyl)-4-Methylphenyl)-D-Glucitol
- (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-<span class="text-smallcaps">D</span>-glucitol
- 1-(β-<span class="text-smallcaps">D</span>-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene
- 1-(β-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-
- Canaglifozin
- Invokana
- Jnj 24831754Zae
- Jnj 28431754
- Jnj 28431754Aaa
- Ta 7284
- Canagliflozin
- D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-
- D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl
- (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
- Canagliflozi
- Cango coluMn net
- Canagliflozin WS
- Canagliflozin, >=98%
- Canaglifozion
- Canagliflozin-D6
- Canagliflozin(TA-7284)
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 18 productos.
Canagliflozin
CAS:Fórmula:C24H25FO5SPureza:≥ 98.0%Forma y color:White to yellow solidPeso molecular:444.52Canagliflozin (Standard)
CAS:Canagliflozin (Standard) is the standard substance of Canagliflozin, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Canagliflozin (JNJ 28431754AAA) is a selective SGLT2 inhibitor that inhibits CHO cells expressing mSGLT2, rSGLT2, and hSGLT2 (IC50=2/3.7/4.4 nM). Canagliflozin can be used for the treatment of type II diabetes mellitus (T2DM).Fórmula:C24H25FO5SPeso molecular:444.52Canagliflozin
CAS:<p>Canagliflozin (JNJ 28431754AAA) is a selective SGLT2 inhibitor. Canagliflozin is used to treat type II diabetes mellitus. Cost-effective and quality-assured.</p>Fórmula:C24H25FO5SPureza:98.01% - >99.99%Forma y color:SolidPeso molecular:444.52Canagliflozin
CAS:Producto controlado<p>Applications Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.<br>References Chao, E. et al.: Drug Fut., 36, 351 (2011); Sha, S. et al.: Diab. Obes. Metab., 13, 669 (2011); Kipnes, M.S.: Clin. Invest., 1, 145 (2011);<br></p>Fórmula:C24H25FO5SForma y color:ColourlessPeso molecular:444.521,5-Dihydroxy Canagliflozin
CAS:Producto controladoFórmula:C24H27FO6SForma y color:NeatPeso molecular:462.531Canagliflozin
CAS:Canagliflozin is a drug that has been approved for the treatment of type 2 diabetes. It is an inhibitor of sodium glucose transporter 2 (SGLT2) and reduces blood glucose levels by increasing urinary glucose excretion. Canagliflozin has been shown to have cardiac effects, which may be due to its ability to increase serum natriuretic peptide levels and decrease heart rate. This drug has also been shown to reduce cardiovascular disease activity in patients with type 2 diabetes. Canagliflozin is not active against c. glabrata, but it does inhibit SGLT1 in this organism.Fórmula:C24H25FO5SPureza:Min. 95%Forma y color:PowderPeso molecular:444.52 g/mol2'-Deshydroxymethyl-2'-Chloromethyl-6'-methoxy-canagliflozin
CAS:Producto controladoFórmula:C25H26ClFO5SForma y color:NeatPeso molecular:492.9872'-Deshydroxymethyl-2'-Chloromethyl-canagliflozin
CAS:Producto controladoFórmula:C24H24ClFO4SForma y color:NeatPeso molecular:462.961(3R,4S,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
CAS:Producto controladoFórmula:C25H27FO6SForma y color:NeatPeso molecular:474.542Canagliflozin Tetra-acetyloxy
CAS:Producto controladoFórmula:C32H33FO9SForma y color:NeatPeso molecular:612.662(2R,3R,4R,5R)-1-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2,3,4,5,6-pentahydroxyhexan-1-one
CAS:Producto controladoFórmula:C24H25FO6SForma y color:NeatPeso molecular:460.515









